Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
EPO Upholds Revocation of 'Important' Affy Patent in Europe, Despite Appeal
According to an attorney familiar with the case, the EPO's decision could have ramifications for the "entire scientific community in Europe" and lead to potential losses in licensing fees for Affy.
New to GenomeWeb? Register quickly here.